JITC

Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway
Kim M van Pul, Ronald J C L M Vuylsteke, Monique T A de Beijer, Rieneke van de Ven, M Petrousjka van den Tol, Hein B A C Stockmann, Tanja D de Gruijl

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000761; DOI: 10.1136/jitc-2020-000761
Evolving impact of long-term survival results on metastatic melanoma treatment
Olivier Michielin, Michael B Atkins, Henry B Koon, Reinhard Dummer, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000948; DOI: 10.1136/jitc-2020-000948
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors
Lillian Siu, Joshua Brody, Shilpa Gupta, Aurélien Marabelle, Antonio Jimeno, Pamela Munster, Juneko Grilley-Olson, Alain H Rook, Antoine Hollebecque, Rebecca K S Wong, James W Welsh, Yuling Wu, Christopher Morehouse, Oday Hamid, Farzana Walcott, Zachary A Cooper, Rakesh Kumar, Charles Ferté, David S Hong

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001095; DOI: 10.1136/jitc-2020-001095
Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
Mitchell W Braun, Haitham Abdelhakim, Meizhang Li, Stephen Hyter, Ziyan Pessetto, Devin C Koestler, Harsh B Pathak, Neil Dunavin, Andrew K Godwin

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000706; DOI: 10.1136/jitc-2020-000706
Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination
Chung-Hsiung Huang, Chiung-Yi Huang, Hui-Min Ho, Ching-Hung Lee, Pang-Ti Lai, Suh-Chin Wu, Shih-Jen Liu, Ming-Hsi Huang

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001022; DOI: 10.1136/jitc-2020-001022
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis
Andrea B Apolo, John A Ellerton, Jeffrey R Infante, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Luc Dirix, Keun-Wook Lee, Matthew H Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Juliane Manitz, Gregory Pennock, Mary Ruisi, James L Gulley, Manish R Patel

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001246; DOI: 10.1136/jitc-2020-001246
KALRN mutations promote antitumor immunity and immunotherapy response in cancer
Mengyuan Li, Yuxiang Ma, You Zhong, Qian Liu, Canping Chen, Lei Qiang, Xiaosheng Wang

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000293; DOI: 10.1136/jitc-2019-000293
Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis
Sienna M Durbin, Meghan J Mooradian, Florian Johannes Fintelmann, Leyre Zubiri, Donald F Chute, Avinash Kambadakone, Nisanard Pisuchpen, Kerry L Reynolds, Michael Dougan

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001329; DOI: 10.1136/jitc-2020-001329
Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy
Xuanwen Bao, Hangyu Zhang, Wei Wu, Shaobing Cheng, Xiaomeng Dai, Xudong Zhu, Qihan Fu, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao, Weijia Fang, Fanglong Liu

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001437; DOI: 10.1136/jitc-2020-001437
Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy
Zachary S Buchwald, Tahseen H Nasti, Judong Lee, Christiane S Eberhardt, Andreas Wieland, Se Jin Im, David Lawson, Walter Curran, Rafi Ahmed, Mohammad K Khan

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000867; DOI: 10.1136/jitc-2020-000867

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages